AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$15.52
−2.14%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.21
- Revenue estimate
- $1.6B
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- $0.21
- EPS estimate
- $0.19
- Revenue actual
- $1.7B
- Revenue estimate
- $1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +4.1%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $14
- PT range
- $8.00 – $16
- Analysts
- 8
1 Buy6 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | $0.19 | $0.21 | Beat 9.37% | $1.7B |
| Apr 29, 2026 | $0.16 | $0.17 | Beat 5.59% | $1.6B |
| Feb 11, 2026 | $0.21 | $0.22 | Beat 4.27% | $1.7B |
| Oct 29, 2025 | $0.23 | $0.22 | Miss -2.65% | $1.6B |
| Aug 1, 2025 | $0.25 | $0.24 | Miss -4.00% | $1.7B |
| Apr 25, 2025 | $0.23 | $0.23 | Miss -0.43% | $1.6B |
| Feb 7, 2025 | $0.25 | $0.27 | Beat 8.43% | $1.7B |
| Oct 25, 2024 | $0.25 | $0.26 | Beat 2.77% | $1.7B |
| Jul 26, 2024 | $0.23 | $0.25 | Beat 7.76% | $1.7B |
| Apr 26, 2024 | $0.20 | $0.22 | Beat 9.45% | $1.7B |
| Feb 14, 2024 | $0.22 | $0.25 | Beat 13.12% | $1.7B |
| Oct 27, 2023 | $0.25 | $0.25 | Miss -0.40% | $1.7B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026